David Katz - Matrix Asset Advisors
Holding/activity history for Marker Therapeutics, Inc. (MRKR)
← All MRKR superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 15,000 | <0.01 | $1.30 | $19,500 | SEC | ||
| 2025 Q4 | 15,000 | <0.01 | $1.49 | $22,350 | SEC | ||
| 2025 Q3 | 15,000 | <0.01 | $0.89 | $13,389 | SEC | ||
| 2025 Q2 | 15,000 | <0.01 | $1.53 | $22,950 | SEC | ||
| 2025 Q1 | 15,000 | <0.01 | $1.23 | $18,450 | SEC | ||
| 2024 Q4 | 15,000 | 0.01 | $3.11 | $46,650 | SEC | ||
| 2024 Q3 | 15,000 | <0.01 | $2.82 | $42,300 | SEC | ||
| 2024 Q2 | 15,000 | 0.01 | $5.40 | $81,000 | SEC | ||
| 2024 Q1 | 15,000 | 0.01 | $4.30 | $64,500 | SEC | ||
| 2023 Q4 | 15,000 | 0.01 | $5.50 | $82,500 | SEC | ||
| 2023 Q3 | 15,000 | 0.01 | Reduce 62.50% | 0.01 | $3.06–9.68 · VW $5.77i | $68,100 | SEC |
| 2023 Q2 | 40,000 | 0.02 | Add 60.00% | <0.01 | $0.72–4.40 · VW $1.74i | $124,000 | SEC |
| 2023 Q1 | 25,000 | <0.01 | $0.71 | $17,750 | SEC | ||
| 2022 Q4 | 25,000 | 0.01 | Reduce 37.50% | <0.01 | $2.20–5.10 · VW $3.49i | $67,500 | SEC |
| 2022 Q3 | 40,000 | 0.02 | Add 60.00% | <0.01 | $2.90–6.60 · VW $4.16i | $148,000 | SEC |
| 2022 Q2 | 25,000 | 0.01 | Add 66.67% | <0.01 | $2.50–4.80 · VW $3.43i | $83,000 | SEC |
| 2022 Q1 | 15,000 | 0.01 | $4.40 | $66,000 | SEC | ||
| 2021 Q4 | 15,000 | 0.02 | Buy | 0.02 | $9.00–17.30 · VW $12.38i | $143,000 | SEC |
Price snapshot:
Current price$1.46
Avg. buy price$4.77
+/- since buy-69.40%
52-week low$0.81
52-week high$4.07